Overview

Clinical Study of ATTR-CM

Status:
Recruiting

Trial end date:
2031-07-01

Target enrollment:
0

Participant gender:
All

Summary

In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Criteria

Inclusion Criteria:

- Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of
Zhejiang University School of Medicine, regardless of gender, age 18-90 years old;

- Patients who have the ability to understand the test and can cooperate with
investigators

Exclusion Criteria:

- Patients who unable to understand or unwilling to fill in informed consent forms or
follow visitors